Smiths Medical ASD Inc. recalls CADD-Solis VIP ambulatory Infusion Pumps
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- The CADD Solis VIP Ambulatory Infusion Pump is indicated for the following uses: " For intravenous, intraarterial, subcutaneous, intraperitoneal, perineural, surgical site, epidural space, or subarachnoid space infusion.
- Products
-
- CADD-Solis VIP ambulatory Infusion Pumps
- Company
- Smiths Medical ASD Inc.
- Where it was sold
-
Worldwide
Nationwide
- Barcodes
1061058604042930610586040430106105860385011061058604259110610586042607106105860426141061058604282915019517084368150195170963851501951709637815019517096392150195171265871061058603889115019517126617150195171499991501951715000115019517150568150195171265941501951712660015019517150292- About this recall
- CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.